SEC Company Response from Edesa Biotech, Inc. (EDSA) (CIK 0001540159) (EDSA) — Sep 10, 2019
Edesa Biotech, Inc. (EDSA) (CIK 0001540159)
Date: Sept. 10, 2019 · CIK: 0001540159 · Accession: 0001654954-19-010495
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-233567
Letter
Blueprint
EDESA BIOTECH, INC.
100 Spy Court
Markham, Ontario, Canada L3R 5H6
September 10, 2019
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:
Edesa Biotech, Inc.
Registration Statement on Form S-3 (File No. 333-233567)
Acceleration Request
Requested Date:
September 12, 2019
Requested Time:
4:00 p.m. Eastern Time
Ladies and Gentlemen:
Edesa Biotech, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-233567) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as possible.
Very truly
yours,
EDESA BIOTECH,
INC.
Show Raw Text
CORRESP
1
filename1.htm
Blueprint
EDESA BIOTECH, INC.
100 Spy Court
Markham, Ontario, Canada L3R 5H6
September
10, 2019
VIA EDGAR
United
States Securities and Exchange Commission
100 F
Street, N.E.
Washington,
D.C. 20549
Re:
Edesa
Biotech, Inc.
Registration
Statement on Form S-3 (File No. 333-233567)
Acceleration
Request
Requested
Date:
September
12, 2019
Requested
Time:
4:00
p.m. Eastern Time
Ladies
and Gentlemen:
Edesa
Biotech, Inc. (the “Company”) hereby requests that the
above-referenced Registration Statement on Form S-3 (File No.
333-233567) (the “Registration Statement”) be
declared effective at the “Requested Date” and
“Requested Time” set forth above or as soon thereafter
as possible.
Very truly
yours,
EDESA BIOTECH,
INC.
Date: September 10,
2019
By:
/s/ Kathi
Niffenegger
Kathi
Niffenegger
Chief Financial
Officer